![Capture](https://www.medtechviews.eu/wp-content/uploads/images/persons/capture_3.png)
Markus Schwertfeger
Senior Global Medical Affairs Lead Roche Diagnostics International
Markus Schwertfeger is Senior Director Medical Affairs at Roche Diagnostics. He has over 20 years of experience in biopharmaceutical and the medtech industry working in various local, regional, and global Medical Affairs roles.
He led teams who launched innovative drugs and managed drug portfolios in various disease areas (cardiovascular, thrombosis, diabetes, metabolism, lipids, neurology, pain, bone, sepsis, oncology) during which time he contributed to shaping activities in clinical development, regulatory framework, pharmacovigilance, and market access.
Before Markus joined the industry he gained clinical experience as a resident in internal medicine in Berlin, Germany and worked as a post-doc at the Institute of Pharmacology and Toxicology of the University of Jena, Germany where his research focus was renal and cardiovascular pharmacology and toxicology.
Markus, a medical doctor, graduated and accomplished a doctoral thesis in pharmacology and toxicology at the Friedrich Schiller University Jena, Germany.
1 blog from the author
![shutterstock_2029745357](https://www.medtechviews.eu/wp-content/uploads/images/articles/shutterstock_2029745357-480x320.jpg)
Posted on 04.11.2021
Heart failure – the time to act is now
With Europe’s ageing population comes several social, economic and environmental benefits. It also brings rising risks of cardiovascular disease (CVD) which must be managed to protect citizens’ wellbeing and the sustainability of our health systems. That is why we are inspired to see 15 European and international health organisations joining forces to form the European […]